We are live on ! Find out more
ANGO icon

AngioDynamics

167 hedge funds and large institutions have $731M invested in AngioDynamics in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 59 increasing their positions, 58 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more capital inflows, than outflows

Capital inflows: $60.8M | Capital outflows: $49.1M

2% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 58

0.93% more ownership

Funds ownership: 98.79% → 99.72% (+0.93%)

6% less funds holding

Funds holding: 178 → 167 (-11)

33% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 24

Holders
167
Holders Change
-11
Holders Change %
-6.18%
% of All Funds
3.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
59
Reduced
58
Closed
24
Calls
$454​K
Puts
–
Net Calls
+$454​K
Net Calls Change
+$426​K

ANGO Hedge Fund Activity: Q2 2019 in Review

167 of the 4,626 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q2 2019, worth a combined $731M — down 13% from $839M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of ANGO and 16 opened new positions — a net loss of 8 holders — while 58 trimmed existing stakes and 59 added.

The largest buyer was Victory Capital Management, adding an estimated $22.1M. The largest seller was Segall Bryant & Hamill, cutting an estimated $4.49M.

  • 167 institutional investors held AngioDynamics (ANGO) as of Q2 2019, down from 178 in Q1 2019.
  • Funds reported $731M of AngioDynamics stock for Q2 2019, down 13% quarter-over-quarter.
  • 16 funds opened new AngioDynamics positions in Q2 2019 and 24 closed out, a net change of -8 holders.
  • The largest AngioDynamics buyer in Q2 2019 was Victory Capital Management, an estimated $22.1M added.
  • The largest AngioDynamics seller in Q2 2019 was Segall Bryant & Hamill, an estimated $4.49M sold.

Based on aggregated 13F filings for Q2 2019.